Calidi Biotherapeutics, Inc. (CLDI) stock
CLDINYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as CLDWW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 3/30
$0.48−0.03 (-5.45%)
Close on Nov 20, 2026Market cap $1.23MP/E –Yield –
Calidi Biotherapeutics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Calidi Biotherapeutics's revenue for the twelve months ending Dec 31, 2022 was $45.00K. For fiscal 2022 it was $45.00K.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $45.00K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2022 | Dec 31, 2022 | $0 | – |
See a number that looks wrong?